Victoria Sholomova

Dr. Victoria Sholomova

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
PGP. V. Glybochko
P. V. Glybochko
VFV. V. Fomin
V. V. Fomin
SMS. V. Moiseev
S. V. Moiseev
SASergey Avdeev
Sergey Avdeev
AYA. G. Yavorovskiy
A. G. Yavorovskiy
ЯАЯковлева Александра Андреевна
Яковлева Александра Андреевна
Aim. In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. Materials and methods. We collected medical records of the intensive care unit patients submitted by the local COVID-19 hospitals across Russia to the Federal Center for the Critical Care at the Sechenov First Moscow State Medical University (Sechenov University). Septic shock in crticially ill patients requiring mechanical ventilation was defined as a need in vasopressors to maintain blood pressure. Results. We studied 1078 patients with severe COVID-19 who were admitted to the intensive care units for respiratory support. There were 611 males and 467 females. The mean age was 61.013.7 years. Five hundred twenty five medical records (48.7%) were received from the Moscow hospitals, 159 (14.7%) from the Moscow region, and 394 (36.5%) from the hospitals located in 58 regions of the Russian Federation. In 613 (56.9%) patients, diagnosis of SARS-CoV-2 infection was confirmed by PCR, and in the other cases it was established on the basis of the clinical picture and the results of the chest CT scan. Septic shock developed in 214 (19.9%) of 1078 patients. In the logistic regression model, the risk of septic shock in patients older than 50 years was higher than in patients of a younger age (OR 2.34; 95% CI 1.533.67; p0.0001). In patients with more severe SARS-CoV-2 infection, there was an increase in the prevalence of cardiovascular diseases, including coronary heart disease and atrial fibrillation, type 2 diabetes and malignant tumors. The risk of septic shock in patients with three or more concomitant diseases was higher than in patients without any concomitant chronic diseases (OR 1.76; 95% CI 1.762.70). Conclusion. The risk of septic shock in patients with acute respiratory distress syndrome induced by SARS-CoV-2 is higher in patients older than 50 years with concomitant diseases, although a severe course of the disease is also possible in younger patients without any concomitant disorders.

23 April 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ASAnastasia Shchepalina
Anastasia Shchepalina
NCNatalia Chebotareva
Natalia Chebotareva
LALarissa Akulkina
Larissa Akulkina
MBMikhail Brovko
Mikhail Brovko
VSVictoria Sholomova
Victoria Sholomova
SMSergey Moiseev
Sergey Moiseev
Background. AKI is one of the COVID-19 complications with high prognostic significance. In our research, we studied the prognostic role of several biomarkers that could help us understand AKI pathogenesis in patients with COVID-19. Methods. We evaluated the medical data of 500 patients hospitalized with COVID-19 in Tareev Clinic from 5 October 2020 to 1 March 2022. The diagnosis of COVID-19 was confirmed with positive RNA PCR in nasopharyngeal swabs and/or typical radiological findings on CT scans. Kidney function was assessed in accordance with KDIGO criteria. In the selected 89 patients, we evaluated serum levels of angiopoetin-1, KIM-1, MAC, and neutrophil elastase 2 and their prognostic significance. Results. The incidence of AKI in our study was 38%. The main risk factors for kidney injury were male sex, cardiovascular diseases, and chronic kidney disease. High serum angiopoetin-1 levels and a decrease in blood lymphocyte count and fibrinogen level also increased the risk of AKI. Conclusions. AKI is an independent risk factor for death in patients with COVID-19. We propose the prognostic model of AKI development, which includes the combination of serum levels of angiopoetin-1 and KIM-1 on admission. Our model can help to prevent AKI development in patients with coronavirus disease.

5 September 2021 in Clinical pharmacology and therapy
Verified
Journal Article
Open access
AMA. Moiseev
A. Moiseev
SMSergey V. Moiseev
Sergey V. Moiseev
ETEkaterina Tao
Ekaterina Tao
NBNikolay Bulanov
Nikolay Bulanov
EMElena Mershina
Elena Mershina
ASA.F. Safarova
A.F. Safarova
To evaluate clinical manifestations and outcomes of Fabry disease (FD) in adult patients in the Russian population.

1 January 2018 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
EPE.N. Popova
E.N. Popova
LSL.A. Strizhakov
L.A. Strizhakov
VSVictoria Sholomova
Victoria Sholomova
APA.B. Ponomarev
A.B. Ponomarev
SMSergey V. Moiseev
Sergey V. Moiseev
VFV.V. Fomin
V.V. Fomin
The article presents a clinical observation of two patients with generalized sarcoidosis. The woman typical granulomatous changes in the lungs and lymph nodes combined with atrial fibrillation, kidney failure and hereditary thrombophilia, men with atherosclerotic coronary arteries, re-myocardial infarction, cholestasis, tubulointerstitial nephritis. The accession of systemic manifestations was accompanied by increase of level of angiotensin-converting enzyme in the blood serum, morphological examination of lung tissue in both cases there were high histological activity of vasculitis and granulomatous inflammation. Extrapulmonary symptoms regressed when conducting immunosuppressive therapy. Discusses modern aspects of diagnosis of sarcoidosis in clinical practice. Keywords: sarcoidosis, extrapulmonary manifestation of sarcoidosis, cardiomyopathy, cardiac rhythm disorder, atherosclerosis

1 October 2018 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
MBMikhail Brovko
Mikhail Brovko
LKLidia Kozlovskaya
Lidia Kozlovskaya
APAndrey Pulin
Andrey Pulin
SMSergey V. Moiseev
Sergey V. Moiseev
VSVictoria Sholomova
Victoria Sholomova
VFVictor Fomin
Victor Fomin
Purpose: Experimental studies suggest that the nephrotic syndrome is associated with “vasopressin escape”, characterized by low aquaporin-2 (AQP2) expression in the collecting duct despite high vasopressin secretion. We investigated this phenomenon in patients with the nephrotic syndrome. Patients and methods: We recruited 47 patients with proteinuric kidney disease who were distributed into the following four groups: 1) nephrotic syndrome with kidney dysfunction (n=10); 2) nephrotic syndrome with normal kidney function (n=16); 3) partial remission of nephrotic syndrome (n=10); and 4) minimal proteinuria (n=11). Nine healthy volunteers comprised a control group. Serum copeptin level (as a marker of vasopressin secretion) and urinary AQP2 were measured using ELISA. Results: Nephrotic syndrome was associated with a significant increase in serum copeptin levels compared with those in the other groups (all P<0.05). In patients with nephrotic syndrome and a partial remission of nephrotic syndrome combined, there was more than a ten-fold decrease in the median urinary AQP2 excretion (0.03 ng/mL) compared with healthy volunteers (0.41 ng/mL; P<0.001) and more than a five-fold decrease compared with patients with minimal proteinuria (0.21 ng/mL; P<0.05). Unlike copeptin levels, the median urinary AQP2 excretion in patients with minimal proteinuria also decreased but less significantly than in those with nephrotic syndrome. There was a negative correlation between the urinary AQP2 excretion and daily proteinuria (R=−0.41; P=0.005). Conclusion: Our clinical study was the first to demonstrate low AQP2 excretion in nephrotic syndrome that may indicate an escape from the vasopressin regulating effect.

1 January 2016 in Terapevticheskii arkhiv
Verified
Journal Article
Closed access
MBM. Yu. Brovko
M. Yu. Brovko
APAndrey Pulin
Andrey Pulin
TKT. Yu. Kustova
T. Yu. Kustova
VSVictoria Sholomova
Victoria Sholomova
OLO. A. Loshkareva
O. A. Loshkareva
LKL. V. Kozlovskaya
L. V. Kozlovskaya
Urinary KIM-1 levels may be used to estimate the activity of CGN with NS and to evaluate the efficiency of treatment. The results of the study substantiate the search for ways of pharmacological blockade of KIM-1 production in the kidney in order to optimize the methods that impact on the pathogenesis of CGN progression.